DeepBiome Therapeutics, Inc

DeepBiome is building a drug discovery platform, applying leading research from top institutions to lower the time and cost barrier of drug discovery with its fast and cost-effective next generation technology. The DeepBiome platform combines artificial intelligence and synthetic biology to rapidly identify potential drug candidates which already exist in the human microbiome. DeepBiome already has proof of concept for IBD to a big pharma partner, the development was under 3 months, a fraction of the time to identify candidate compounds using traditional methods.


VISIT WEBSITE Back to Portfolio